NYSE: EWEdwards Lifesciences Corp

HealthcareMkt Cap $51.82BCongress ownership rank #212

Edwards Lifesciences Corp Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 127 trades in Edwards Lifesciences Corp (NYSE: EW) since 2014, across 22 members, worth an estimated $1.4M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 68 buys against 59 sells, a modestly buy-led skew, with Democratic members responsible for 48% of the trades and Republican members 52%. The most recent disclosure shown was filed September 2026, and Rohit Khanna has filed the most EW transactions among those shown, with 13. Other recent filers include Alan Armstrong and Josh Gottheimer. One notable disclosed move was a purchase by Rohit Khanna on April 13, 2026, up 15.1% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Edwards Lifesciences Corp's current Quantellect Tide Score is 34 out of 100 (Calm Tide), Bottom 13% of universe (3990); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Edwards Lifesciences Corp (EW) stock overview and the complete trade table below.